deepmirror
@deepmirror.bsky.social
On a mission to empower scientists by bridging human ingenuity and technology, accelerating the journey from idea to patient impact.
🚀 We’re hiring Science & Technology Leads at ARIA Help shape bold, high-risk R&D at the frontier of science and tech. Opportunities: • Mathematics for Safe AI • Nature Computes Better • Trust Everything, Everywhere • Smarter Robot Bodies 👉 https://aria.pinpointhq.com/
Careers at ARIA
Learn more about working at ARIA and discover our latest career opportunities
aria.pinpointhq.com
🚨 Final call: We’re looking for a communications & engagement partner to work alongside our team, bringing strong strategic and creative capabilities. Help us enhance ARIA’s visibility, strengthen our narrative, and amplify the impact of our programmes. ⏰ Deadline 1 May: https://bit.ly/4d9oDWI
Supply to us
From core operational services to specialised programme support, we work with providers who can help us run efficiently and effectively.
bit.ly
🚀 ARIA is looking for a partner to help deliver our R&D programmes and improve how we operate. Acting as an embedded extension of ARIA, you’ll support decision-making and delivery across the portfolio. 📅 Webinar 26 May: https://bit.ly/49k8Odt ⏰ Proposals due: 16 June: https://bit.ly/4d9oDWI
Video Conferencing, Web Conferencing, Webinars, Screen Sharing
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom ...
bit.ly
In our latest newsletter, we highlighted our affiliated company deepmirror, an AI-powered molecular design platform for drug hunters! 🔗 View the spotlight in our November newsletter: https://milner.glueup.com/organization/7082/campaign/0VLiS8O2mD7zgPyBMwtAaw%3D%3D/
Can AI help democratize the global fight against #malaria? In @healthpolicywatch.bsky.social, MMV’s Jeremy Burrows explains how AI could speed up drug discovery and how a new platform with @deepmirror.bsky.social aims to make these tools more accessible worldwide. Read: bit.ly/4aj84GU
Interview: Can AI democratize the global fight against malaria? | Medicines for Malaria Venture
An interview with MMV's Head of Drug Discovery on how artificial intelligence could compress years of drug discovery into months - helping to overcome growing drug resistance to existing treatments fo...
bit.ly
Scenes from last week’s co-creation workshop in Accra, where MMV & @deepmirror.bsky.social convened a group of Africa-based researchers convened to learn about & shape the continued development of the AI-powered Drug Discovery for Global Health platform. More 👉 bit.ly/4qeyz55
AI in drug discovery only matters if scientists in high-burden settings can use it. Last December, African researchers tested MMV & @deepmirror.bsky.social's dd4gh platform. PhD computational analyst Caroline Maina says it could help identify promising TB compounds.
Time and cost are often the biggest barriers in early drug discovery, especially for researchers in endemic settings. @suhealthsci.bsky.social postdoc Jessica Thibaud says MMV & @deepmirror.bsky.social’s dd4gh could change early-stage computational studies. 🎥
Cost and complexity put AI tools for drug discovery out of reach for many, but dd4gh is changing that. Watch Max Jakobs of @deepmirror.bsky.social explain how accessibility and pooled data can level the playing field for drug discovery researchers around the world.
MMV & @deepmirror.bsky.social have launched dd4gh, an open-access AI platform giving researchers in LMICs access to advanced drug discovery tools. Designed to reduce costs & timelines, dd4gh is levelling the playing field for all scientists shaping research into #malaria & other diseases.
We’re excited to officially launch #dd4gh (Drug Design for Global Health) in partnership with Medicines for Malaria Venture @mmv.org If you’re working on global health challenges, you can learn more and apply for access here: 👉 www.dd4gh.ai
dd4gh - Drug Design for Global Health
dd4gh is a free, open-access AI platform by Medicines for Malaria Venture and deepmirror that helps researchers design and prioritise drug candidates for global health challenges.
dd4gh.ai
🚀 September @deepmirror.bsky.social newsletter is live! Catch up on our latest platform updates and breakthroughs in AI-powered drug discovery: 💻 Product updates - Refinement for protein–ligand co-folding - Several quality-of-life improvements
@deepmirror.bsky.social is fully committed to global health. Co-creating dd4gh will help teams to: 🚀 Accelerate discovery of promising compounds 🫶 Build a more inclusive global research community Next: Accra in December. 🗞️ Press Release: www.deepmirror.ai/post/co-crea...
Co-creating an innovative AI platform to advance global health research | deepmirror
Researchers from around the world collaborate with MMV and deepmirror to adapt machine-learning platform to accelerate drug discovery.
deepmirror.ai
Proud of our joint effort with @mmv.org teams to co-create dd4gh - an AI platform accelerating drug discovery to eliminate hashtag#malaria and advance global health. 🌍
Today, MMV and @deepmirror.bsky.social convened 40+ scientists in Geneva to co-create the dd4gh platform. Together, we’re using AI/ML to accelerate #malaria drug discovery while building a more inclusive global research community. Next stop: Accra. 👉 Read more: bit.ly/46xigrJ
🌻 Welcome to our new affiliate, @deepmirror.bsky.social! deepmirror's co-ideation platform generates drug designs that complement the intuition of chemists, enabling R&D teams to accelerate progress towards the clinic. 🔗 Read more at: deepmirror.ai.
🔗 Read the full newsletter: deepmirror.substack.com/p/deepmirror... #ChemSky #MedChem #CompChem #AI #DrugDiscovery
deepmirror update | August 2025
New ways to prioritise molecules and classification models on deepmirror, plus the first approved malaria medicine for newborn babies.
deepmirror.substack.com
✨ deepmirror update | June 2025 ✨ The new monthly newsletter from @deepmirror.bsky.social is live! Find out: - the latest improvements to the platform - news from the AI for drug discovery community - a calendar of events where you can meet the team deepmirror.substack.com/p/deepmirror...
deepmirror update | June 2025
Improvements to molecule generation & Summer meet-ups
deepmirror.substack.com
@deepmirror.bsky.social is heading to Chicago for @acsmedi.bsky.social & @euromedchem.bsky.social Medicinal Chemistry Frontiers 2025! 🏙️ If you’re also attending or happen to be in the Chicago area, I’d love to connect. Drop me a message or visit us at Booth 16 - let’s grab a ☕ and 💬!
The need to accelerate #innovation to strengthen global health security has never been greater. MMV and @deepmirror.bsky.social have joined forces to harness #AI and machine learning to support next-gen drug discovery and facilitate access to cutting-edge tech for scientists in LMICs.
Join @deepmirror.bsky.social’s first open Lunchtime Learning Lecture (L³) this Thursday! 🎤 Miruna Cretu (@mirunacretu.bsky.social), PhD researcher at the University of Cambridge 🔬Design of Synthesisable Molecules with GFlowNets 📅 Thursday, March 6, 12:30–13:30 📍 Online & In-person 🎟️ lu.ma/381gxksg
Lunchtime Learning Lecture · Luma
We’re excited to host our first public Lunchtime Learning Lecture! A casual, central London based, series of talks around AI & Drug Discovery. Speaker: Miruna…
lu.ma
We’re #hiring! @deepmirror.bsky.social is looking for a Molecular AI Engineer and a PhD Research Intern. If you share our vision to empower scientists by bridging human brilliance and technology in the life sciences, we’d love to hear from you. Please share or apply via the links below!
